Non-Infectious Uveitis and Pregnancy, is There an Optimal Treatment? Uveitis Course and Safety of Uveitis Treatment in Pregnancy.

Ting, Magdalene Yin Lin; Vega-Tapia, Fabian; Anguita, Rodrigo; Cuitino, Loreto; Valenzuela, Rodrigo A; Salgado, Felipe; Valenzuela, Omar; Ibañez, Sebastian; Marchant, Ruben; Urzua, Cristhian A (2024). Non-Infectious Uveitis and Pregnancy, is There an Optimal Treatment? Uveitis Course and Safety of Uveitis Treatment in Pregnancy. (In Press). Ocular immunology and inflammation, pp. 1-13. Taylor & Francis 10.1080/09273948.2023.2296030

[img] Text
Non-Infectious_Uveitis_and_Pregnancy_is_There_an_Optimal_Treatment_Uveitis_Course_and_Safety_of_Uveitis_Treatment_in_Pregnancy.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

In pregnancy, a plethora of factors causes changes in maternal immunity. Uveitis flare-ups are more frequent in the first trimester and in undertreated patients. Management of non-infectious uveitis during pregnancy remains understudied. A bibliographic review to consolidate existing evidence was performed by a multidisciplinary group of Ophthalmologists, Gynaecologists and Rheumatologists. Our group recommends initial management with minimum-required doses of corticosteroids, preferably locally, to treat intraocular inflammation whilst ensuring good neonatal outcomes. If ineffective, clinicians should consider addition of Cyclosporine, Azathioprine or Certolizumab pegol, which are seemingly safe in pregnancy. Other therapies (such as Methotrexate, Mycophenolate Mofetil and alkylating agents) are teratogenic or have a detrimental effect on the foetus. Furthermore, careful multidisciplinary preconception discussions and close follow-up are recommended, monitoring for flare-ups and actively tapering medication doses, with a primary endpoint focused on protecting ocular tissues from inflammation, whilst giving minimal risk of poor pregnancy and foetal outcomes.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology

UniBE Contributor:

Anguita Henríquez, Rodrigo Andrés

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1744-5078

Publisher:

Taylor & Francis

Language:

English

Submitter:

Pubmed Import

Date Deposited:

10 Jan 2024 13:11

Last Modified:

11 Jan 2024 17:36

Publisher DOI:

10.1080/09273948.2023.2296030

PubMed ID:

38194442

Uncontrolled Keywords:

Steroids TNF-α inhibitors immunosuppressive agents pregnancy uveitis

BORIS DOI:

10.48350/191418

URI:

https://boris.unibe.ch/id/eprint/191418

Actions (login required)

Edit item Edit item
Provide Feedback